Search filters

List of works by Aneta Rogalska

Aclarubicin in subtoxic doses reduces doxorubicin cytotoxicity in human non-small cell lung adenocarcinoma (A549) and human hepatocellular carcinoma (HepG2) cells by decreasing DNA damage

scientific article published on 20 December 2018

Aclarubicin-induced ROS generation and collapse of mitochondrial membrane potential in human cancer cell lines

scientific article

Aclarubicin-induced apoptosis and necrosis in cells derived from human solid tumours.

scientific article published on 24 April 2010

Activation of apoptotic pathway in normal, cancer ovarian cells by epothilone B.

scientific article published on 19 June 2013

Analysis of epothilone B-induced cell death in normal ovarian cells.

scientific article published on 12 September 2013

Antileukemic activity of novel adenosine derivatives

scientific article published on 01 October 2019

Caspases and ROS - dependent mechanism of action mediated by combination of WP 631 and epothilone B.

scientific article

Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer

scientific article published on 29 May 2021

Cytotoxicity and induction of apoptosis by formamidinodoxorubicins in comparison to doxorubicin in human ovarian adenocarcinoma cells

scientific article published on 18 December 2014

Early Activation of Apoptosis and Caspase-independent Cell Death Plays an Important Role in Mediating the Cytotoxic and Genotoxic Effects of WP 631 in Ovarian Cancer Cells

scientific article published on January 2015

Early Activation of Apoptosis and Caspase-independent Cell Death Plays an Important Role in Mediating the Cytotoxic and Genotoxic Effects of WP 631 in Ovarian Cancer Cells

scientific article published on 11 January 2016

Effect of metformin on apoptosis induction in ovarian cancer cells.

scientific article published on 29 June 2014

Effects of Epothilone A in Combination with the Antidiabetic Drugs Metformin and Sitagliptin in HepG2 Human Hepatocellular Cancer Cells: Role of Transcriptional Factors NF-κB and p53

scientific article published on 11 April 2016

Effects of Epothilone A in Combination with the Antidiabetic Drugs Metformin and Sitagliptin in HepG2 Human Hepatocellular Cancer Cells: Role of Transcriptional Factors NF-κB and p53.

scientific article published on January 2016

Effects of metformin on the survival of the SKOV-3 ovarian cancer cell line and the expression of genes encoding enzymes involved in O-Glcnacylation

scientific article published in July 2014

Epothilone B induces extrinsic pathway of apoptosis in human SKOV-3 ovarian cancer cells.

scientific article published on 26 February 2014

Epothilone B induces human ovarian cancer OV-90 cell apoptosis via external pathway.

scientific article

Epotilony – nadzieja dla pacjentów niewrażliwych na leczenie taksanami

scientific article published in 2010

Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells

scientific article

Hyperglycemia-Associated Dysregulation of O-GlcNAcylation and HIF1A Reduces Anticancer Action of Metformin in Ovarian Cancer Cells (SKOV-3)

scholarly article by Aneta Rogalska published in September 2018

Identification of the key pathway of oxazolinoanthracyclines mechanism of action in cells derived from human solid tumors

scientific article

Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B.

scientific article

Inhibitors of microtubule polymerization- new natural compounds as potential anti-cancer drugs

scientific article

Metformin Affects Olaparib Sensitivity through Induction of Apoptosis in Epithelial Ovarian Cancer Cell Lines

scientific article published on 29 September 2021

Metformin and epothilone A treatment up regulate pro-apoptotic PARP-1, Casp-3 and H2AX genes and decrease of AKT kinase level to control cell death of human hepatocellular carcinoma and ovary adenocarcinoma cells

scientific article

Metformin, but not sitagliptin, enhances WP 631-induced apoptotic HepG2 cell death

scientific article published on 8 May 2015

New potential chemotherapy for ovarian cancer - Combined therapy with WP 631 and epothilone B.

scientific article published on March 2016

Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells

scientific article published on 17 November 2022

Novel oxazolinoanthracyclines as tumor cell growth inhibitors-Contribution of autophagy and apoptosis in solid tumor cells death

scientific article published on 24 July 2018

Nuclear DNA Damage and Repair in Normal Ovarian Cells Caused by Epothilone B

scientific article published on 6 October 2015

Nuclear DNA Damage and Repair in Normal Ovarian Cells Caused by Epothilone B.

scientific article published on January 2015

PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality-An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness

scientific article published on 19 December 2020

PARP inhibitor resistance in ovarian cancer: Underlying mechanisms and therapeutic approaches targeting the ATR/CHK1 pathway

scientific article published in December 2021

Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer

scientific article published on 21 April 2020

Pro-apoptotic activity of new analog of anthracyclines--WP 631 in advanced ovarian cancer cell line.

scientific article published on 25 November 2013

Relationship between in vitro drug sensitivity and clinical response of patients to treatment in chronic lymphocytic leukemia

scientific article published on 08 January 2015

Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells

scientific article published on 09 June 2020

Ruthenium dendrimers against acute promyelocytic leukemia: in vitro studies on HL-60 cells

scientific article published on 09 July 2019

Suppression of autophagy enhances preferential toxicity of epothilone A and epothilone B in ovarian cancer cells

scientific article published on 31 January 2019

Synthesis and In Vitro Activity of Novel Melphalan Analogs in Hematological Malignancy Cells

scientific article published on 3 February 2022

The Influence of PARP, ATR, CHK1 Inhibitors on Premature Mitotic Entry and Genomic Instability in High-Grade Serous and Ovarian Cancer Cells

scientific article published on 10 June 2022

The connection between the toxicity of anthracyclines and their ability to modulate the P-glycoprotein-mediated transport in A549, HepG2, and MCF-7 cells.

scientific article

The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin

scientific article

Therapeutic potential of patupilone in epithelial ovarian cancer and future directions.

scientific article published in May 2018

Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies-Current Research and Clinical Approaches

scientific article published on 23 April 2021

Tumour protein 53 is linked with type 2 diabetes mellitus

scientific article published in August 2017

WP 631 and Epo B synergize in SKOV-3 human ovarian cancer cells

scientific article

Why a Combination of WP 631 and Epo B is an Improvement on the Drugs Singly - Involvement in the Cell Cycle and Mitotic Slippage

scientific article

Why a Combination of WP 631 and Epo B is an Improvement on the Drugs Singly - Involvement in the Cell Cycle and Mitotic Slippage

scientific article published on 11 April 2016

[TUBB3 role in the response of tumor cells to epothilones and taxanes]

scientific article published on 28 January 2015